Caspases influence the mode but not the extent of cell death induced by purine analogues in chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 109, Issue 4, 2000, Pages 800-804

  Pettitt, A R ^a,b   Cawley, J C ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Caspases; Chlorodeoxyadenosine; Chronic lymphocytic leukaemia (CLL); Fludarabine

Indexed keywords

CASPASE; CASPASE INHIBITOR; CLADRIBINE; DNA FRAGMENT; FLUDARABINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PURINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL DEATH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL MEMBRANE; CELL SIZE; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; VIDARABINE;

EID: 0033866737     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02068.x     Document Type: Article

References (17)

1. Bellosillo, B., Dalmau, M., Colomer, D. & Gil, J. (1997) Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood, 89, 3378-3384.
2. Chandra, J., Gilbreath, J., Friereich, E.J., Kliche, K.-O., Andreef, M., Keating, M. & McConkey, D.J. (1997) Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood, 90, 3673-3681.
3. Green, D.R. (1998) Apoptotic pathways: the roads to ruin. Cell, 94, 695-698.
4. Green, D.R. & Kroemer, G. (1998) The central executioners of apoptosis: caspases or mitochondria? Trends in Cell Biology, 8, 267-271.
5. Green, D.R. & Reed, J.C. (1998) Mitochondria and apoptosis. Science, 281, 1309-1312.
6. Earnshaw, W.C. (1999) A cellular poison cupboard. Nature, 397, 387-389.
7. Hirsch, T., Marchetti, P., Susin, S.A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M. & Kroemer, G. (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene, 15, 1573-1581.
8. Kaufmann, S.H., Desnoyers, S., Ottaviano, Y., Davidson, N.E. & Poirier, G.G. (1993) Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Research, 53, 3976-3985.
9. Koopman, G., Reutelingsperger, C.P.M., Kuijten, G.A.M., Keehnan, R.M.H., Pals, S.T. & van Oers, M.H.J. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84, 1415-1420.
10. Kroemer, G., Zamzami, N. & Susin, S.A. (1997) Mitochondrial control of apoptosis. Immunology Today, 18, 44-51.
11. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. & Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. Journal of Immunological Methods, 139, 271-279.
12. Pettitt, A.R., Sherrington, P.D. & Cawley, J.C. (1999) The effect of p53 dysfunction on purine analogue cytotoxicity in chronic lymphocytic leukaemia. British Journal of Haematology, 106, 1049-1051.
13. Susin, S.A., Zamzami, N., Castedo, M., Daugas, E., Wang, H.-G., Geley, S., Fassy, F., Reed, J.C. & Kroemer, G. (1997) The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. Journal of Experimental Medicine, 186, 25-37.
14. Thornberry, N.A. & Lazebnik, Y. (1998) Caspases: enemies within. Science, 281, 1312-1316.
15. Villa, P., Kaufmann, S.H. & Earnshaw, W.C. (1997) Caspases and caspase inhibitors. Trends in Biochemical Science, 22, 388-393.
16. Wyllie, A.H. (1998) An endonuclease at last. Nature, 391, 20-21.
17. Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssiere, J.L., Petit, P.X. & Kroemer, G. (1995) Reduction in mitochondrial membrane potential constitutes an early irreversible step of programmed lymphocyte death in vivo. Journal of Experimental Medicine, 181, 1661-1672.